Covered recipient · General Payments record
STACEY H EARLS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,066.05
- Reported across 60 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $237.95 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $95.41 | 4 |
| Novo Nordisk AS | $77.38 | 4 |
| Xeris Pharmaceuticals, Inc. | $19.36 | 1 |
| Acerta Pharma LLC | $16.34 | 1 |
| Astellas Pharma US Inc | $15.69 | 1 |
| Amgen Inc. | $13.77 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.14 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107056456 | CMS |
| ABBVIE INC. | $27.85 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107056458 | CMS |
| ABBVIE INC. | $21.44 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107056460 | CMS |
| ABBVIE INC. | $17.98 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107056462 | CMS |
| Amgen Inc. | $13.77 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117546610 | CMS |
| Astellas Pharma US Inc | $15.69 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139483278 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.34 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105747771 | CMS |
| Novo Nordisk Inc | $24.15 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100579510 | CMS |
| Novo Nordisk Inc | $17.56 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100420655 | CMS |
| Novo Nordisk Inc | $18.85 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100408624 | CMS |
| Novo Nordisk Inc | $16.82 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100510559 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.36 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144639050 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.